ELVN R&D Expense Growth
Enliven Therapeutics Inc · R&D Expense Growth
ELVN R&D Expense Growth
Latest reported6.29%period ending
ELVN FY R&D Growth (YoY) (0.00% → 6.29%)
Latest values, visible window
High-resolution chart · PNG
ELVN r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 6.2864% | |
| 25.0937% | |
| 108.1555% | |
| 51.519% | |
| 148.4709% | |
| -56.6521% | |
| 130.7197% | |
| 4.0541% | |
| 0% |